Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.
-
Khanna D
University of Michigan Scleroderma Program, Ann Arbor, MI, USA.
-
Furst DE
UCLA, Los Angeles, CA, USA.
-
Clements PJ
UCLA, Los Angeles, CA, USA.
-
Allanore Y
Paris Descartes University, rheumatology A dpt, Cochin Hospital, Paris, France.
-
Baron M
Department of Medicine, McGill University Division of Rheumatology Jewish General Hospital, Montréal, Canada.
-
Czirjak L
Department of Immunology and Rheumatology, University of Pécs, Hungary.
-
Distler O
Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
-
Foeldvari I
Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany.
-
Kuwana M
Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, 2Tokyo, Japan.
-
Matucci-Cerinic M
Department of Experimental & Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Firenze, Italy.
-
Mayes M
University of Texas McGovern Medical School, Houston, TX, USA.
-
Medsger T
University of Pittsburgh, Pittsburgh, PA, USA.
-
Merkel PA
University of Pennsylvania, Philadelphia, PA, USA.
-
Pope JE
Deparment of Medicine, University of Western Ontario, London, ON, Canada.
-
Seibold JR
Scleroderma Research Consultants LLC, Litchfield, CT, USA.
-
Steen V
Georgetown University, Washington DC, USA.
-
Stevens W
Division of Rheumatology, St. Vincent's Hospital, Melbourne, Australia.
-
Denton CP
Centre for Rheumatology, Royal Free and University College London Medical School, London, UK.
Show more…
Published in:
- Journal of scleroderma and related disorders. - 2017
English
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/204069
Statistics
Document views: 25
File downloads: